COMMUNIQUÉ DE PRESSE publié le 04/03/2026 à 07:30, il y a 6 mois 6 jours SIXT achieves record year 2025: Currency adjusted revenue increased by around 9% to EUR 4.3 billion – profit rises by almost 20% Sixt SE achieves record year 2025 with nearly 9% revenue growth to EUR 4.3 billion & 20% profit increase. Plans for continued growth in 2026 with expanded mobility platform Revenue Growth Record Year Profit Increase Sixt SE Mobility Platform
COMMUNIQUÉ DE PRESSE publié le 04/03/2026 à 07:03, il y a 6 mois 6 jours EQS-Adhoc: adidas AG extends Bjørn Gulden’s contract as Chief Executive Officer and initiates transition at the helm of the Supervisory Board adidas AG extends Bjørn Gulden’s contract as Chief Executive Officer and initiates transition at the helm of the Supervisory Board. Key personnel decisions announced Supervisory Board Chief Executive Officer Personnel Decisions Adidas AG Bjørn Gulden
COMMUNIQUÉ RÉGLEMENTÉ publié le 04/03/2026 à 07:02, il y a 6 mois 6 jours TERACT - Availibility of the Half-year Financial Report As of 31 December 2025 TERACT announces availability of its half-year financial report as of 31 December 2025, compliant with regulations, filed with AMF and accessible on company and AMF websites Financial Statements TERACT AMF Regulations Half-year Financial Report
COMMUNIQUÉ RÉGLEMENTÉ publié le 04/03/2026 à 07:02, il y a 6 mois 6 jours TERACT - Mise à disposition du Rapport Financier Semestriel au 31 décembre 2025 TERACT annonce la mise à disposition de son Rapport Financier Semestriel au 31 décembre 2025 conforme à la réglementation en vigueur. Consultation possible sur www.teract.com ou le site de l'AMF TERACT AMF Investisseurs Publication Rapport Financier Semestriel
COMMUNIQUÉ RÉGLEMENTÉ publié le 04/03/2026 à 07:02, il y a 6 mois 6 jours TERACT - H1 2025-2026 results TERACT's H1 2025-2026 results impacted by store disposals amid sluggish market conditions. InVivo Group proposes public buy-out and squeeze-out of TERACT shares to support new roadmap TERACT Results Store Disposals InVivo Group H1 2025-2026
COMMUNIQUÉ RÉGLEMENTÉ publié le 04/03/2026 à 07:02, il y a 6 mois 6 jours TERACT - Résultats du 1er semestre 2025-2026
COMMUNIQUÉ DE PRESSE publié le 04/03/2026 à 07:00, il y a 6 mois 6 jours Fourth quarter 2025 Results - EUR 208 million net income in Q4 2025, contributing to a strong full year net income of EUR 851 million - Proposed regular dividend of EUR 1.9 per share SCOR SE reports EUR 208 million net income in Q4 2025, contributing to a strong full year net income of EUR 851 million. Proposed regular dividend of EUR 1.9 per share approved by the Board Financial Results Net Income Dividend Scor SE Q4 2025
COMMUNIQUÉ DE PRESSE publié le 04/03/2026 à 07:00, il y a 6 mois 6 jours BioVersys Announces Publication of BV100 Phase 1 Clinical Data in Journal of Antimicrobial Agents and Chemotherapy BioVersys announces publication of BV100 Phase 1 clinical data in Journal of Antimicrobial Agents and Chemotherapy Clinical Data Phase 1 BV100 BioVersys Antibacterial
COMMUNIQUÉ DE PRESSE publié le 04/03/2026 à 06:45, il y a 6 mois 6 jours Anja Hendel, Max Müller and Peter Schmid von Linstow to be nominated to the Supervisory Board of Redcare Pharmacy. Anja Hendel, Max Müller and Peter Schmid von Linstow nominated to Redcare Pharmacy's Supervisory Board, enhancing expertise & strategic oversight. Björn Söder, Jérôme Cochet, Jaska de Bakker to step down Governance Supervisory Board Expertise Redcare Pharmacy Nominees
COMMUNIQUÉ DE PRESSE publié le 04/03/2026 à 06:44, il y a 6 mois 6 jours PALFINGER AG – THIRD-BEST FISCAL YEAR IN THE COMPANY'S HISTORY AND FOCUS ON PROFITABLE GROWTH PALFINGER AG reports third-best fiscal year, with EUR 2.34 billion revenue, EUR 174.3 million EBIT, and focus on profitable growth. Strong balance sheet and global expansion strategies Global Expansion Financial Performance Profitable Growth Fiscal Year PALFINGER AG
Publié le 10/09/2026 à 19:30, il y a 10 heures 46 minutes Availability of the 2026 Interim Financial Report
Publié le 10/09/2026 à 19:30, il y a 10 heures 46 minutes Mise à disposition du Rapport Financier Semestriel 2026
Publié le 10/09/2026 à 18:10, il y a 12 heures 6 minutes LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 août 2026
Publié le 10/09/2026 à 17:45, il y a 12 heures 31 minutes COGRA : RÉSULTATS ANNUELS 2025/26 - Retour à la croissance rentable et structure financière renforcée
Publié le 10/09/2026 à 17:42, il y a 12 heures 33 minutes Déclaration d'actions et de droits de vote au 31.08.2026
Publié le 11/09/2026 à 04:00, il y a 2 heures 16 minutes Torq Announces Debt Settlement and Corporate Update
Publié le 10/09/2026 à 22:25, il y a 7 heures 51 minutes Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Publié le 10/09/2026 à 15:20, il y a 14 heures 56 minutes MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Publié le 10/09/2026 à 15:00, il y a 15 heures 16 minutes All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Publié le 11/09/2026 à 00:05, il y a 6 heures 11 minutes Club Offers for Travel Enthusiasts in Germany
Publié le 11/09/2026 à 00:01, il y a 6 heures 15 minutes Club Offers for Travel Enthusiasts in Germany
Publié le 10/09/2026 à 22:39, il y a 7 heures 36 minutes EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Publié le 10/09/2026 à 22:10, il y a 8 heures 5 minutes flatexDEGIRO with changes to the Supervisory Board
Publié le 10/09/2026 à 22:07, il y a 8 heures 9 minutes EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board